JAMIE BARTLETT: Open Payments
NPI 1467856773 · PRINCETON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 72 payments from 22 companies in 2025. Trend: 2023 $776 · 2024 $1,073 · 2025 $1,174
Food & beverage: $1,129Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $292 |
| Axsome Therapeutics, Inc. | 14 | $201 |
| Novo Nordisk Inc | 5 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Phathom Pharmaceuticals, Inc. | 5 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Exact Sciences Corporation | 3 | $46 |
| Lilly USA, LLC | 1 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
Products named: Auvelity, UBRELVY, QULIPTA, VRAYLAR, GLASSIA, VOQUEZNA, Wegovy, REXULTI.
Industry payments across IN — which companies pay providers there.
